Preface: Cellular and Molecular Targets in Allergy and Clinical Immunology | |
Carl Prausnitz Lecture | |
From Wheals and Wheeze to Tolerance: Allergy quo vadis? | p. 1 |
Inflammatory Effector Cells | |
Regulation of c-Kit Expression in Human Mast Cells: Inhibition of SCF-Induced c-Kit Downregulation by STI 571 (Gleevec) in LAD 2 and HMC-1 Cells | p. 11 |
Costimulation of Mast Cells via Fc[epsilon]RI and Toll-Like Receptors Markedly Augments Production of Inflammatory Cytokines | p. 15 |
Escherichia coli Hemolysin Provokes Mast Cell Activation | p. 20 |
Surface Expression, Inhibitory Function and Candidate Ligand for Siglec-8 on Human Mast Cells | p. 23 |
Pharmacologic Regulation of Eosinophil Activation: New Therapeutic Targets | p. 27 |
Eosinophil Progenitors at Birth: Intimations of Future Atopy and Inflammation | p. 29 |
CXCR3 Ligand Production by Human Mast Cells in Response to Infection Associated Stimuli | p. 32 |
Molecular Mechanism of Hygiene Hypothesis | p. 36 |
Vascular Endothelial Growth Factor-A Is Stored in and Immunologically Released from Human Basophils | p. 38 |
Identification of Nitric Oxide Regulated Genes with Potential Roles in Signaling in Mast Cells | p. 43 |
Molecular Mechanisms for Regulation of the Human High-Affinity IgE Receptor [beta] Subunit (Fc[epsilon]RI[beta]) Gene Expression | p. 46 |
Integrating Control of Mast Cell Function and Allergic Responses | p. 49 |
Gene Expression Profiling of Human Mast Cell Lines | p. 54 |
In vivo Imaging of Activated Eosinophils in Inflamed Tissues | p. 58 |
Aspirin-Sensitive Rhinosinusitis Is Associated with Reduced E-Prostanoid 2 (EP2) Receptor Expression on Nasal Mucosal Inflammatory Cells | p. 61 |
Effects of Lipid Mediators on the Activation of Human Lung Fibroblasts | p. 63 |
Potentially Novel Mediators of Mast Cell-Sensory Nerve Interactions | p. 66 |
Allergens | |
Purification of the Natural Peanut Allergen Ara h 1 | p. 70 |
Apples Can Drive Birch-Pollen-Allergic Patients Nuts! T-Cell Crossreactivity as a Basis for Food Allergy | p. 73 |
Mass Spectroscopic Analysis of Natural and Recombinant Preparations of Pollen (Birch, Grass, Olive) and House Dust Mite Allergens | p. 77 |
Identification of the Major Components of the Dust Mite Proteome and the Full Repertoire of Its Allergens | p. 80 |
Nitration of Allergens: Another Pollution Effect to Be Concerned About | p. 84 |
Modulation of the IgE Response by Blocking Membrane-IgE | p. 87 |
Artemisia and Ambrosia Hypersensitivity: Cosensitization or Corecognition? A Study Using Recombinant Weed Pollen Allergens | p. 90 |
Cytokine Responses in Peanut Nonallergic Adults Are Dominated by Th2-Like Responses in the Absence of Detectable Th1 Function | p. 93 |
Recombinant Hybrid Molecule Consisting of rPhI p 1, 2, 5, and 6: Is it the Best Combination for Grass Pollen Diagnosis in a Group of French Patients? | p. 97 |
Epitope Mapping and Characterization of the Binding Specificity of Monoclonal Antibodies Directed Against Allergens of Grass Group 1 | p. 100 |
Relevance of Carbohydrate Determinants in Differentiating True Latex Allergy from Asymptomatic IgE Reactivity | p. 103 |
Immunoglobulin Free Light Chains in Hypersensitivity Reactions: Need for Crosslinking by Antigens | p. 106 |
Vacuolar Serine Proteases from Cladosporium herbarum and Alternaria alternata | p. 109 |
Pollen Pave Their Way: Th2 Micromilieu Generated by Pollen-Associated Lipid Mediators (PALMs) | p. 113 |
More Than 50% of Positive Challenges with Foods Are Associated with Late Eczematous Reactions in Atopic Dermatitis | p. 118 |
Immunotherapy and Pharmacotherapy | |
Elevated Histamine Release in Chimeric IgE/IgG1 Antigen Receptor Knock-in- Mice | p. 121 |
Mechanisms of Inhibition of Human Allergic Th2 Immune Responses by Regulatory T-Cells Induced by Interleukin 10-Treated Dendritic Cells and Transforming Growth Factor [beta] | p. 124 |
Anaphylactic and Anaphylactoid Reactions to Paclitaxel, Carboplatin, and Doxorubicin: Treatment with Rapid Desensitization | p. 128 |
Regulatory Natural Killer Cells Suppress Antigen-Specific T Cell Responses | p. 131 |
Environmental Prenatal Factors of Allergy in Lithuania | p. 134 |
Antibody Responses to Minor Allergen Bet v 2 During Allergen-Specific Immunotherapy in Birch Pollen-Allergic Patients | p. 138 |
Induction of "Regulatory" T-Cells by Cynodon dactylon-Specific Allergen Immunotherapy | p. 142 |
[alpha]-Melanocyte Stimulating Hormone and Fragments: Potential Therapeutic Agents in Inflammation | p. 147 |
Mechanisms of Immune Tolerance to High Dose Allergen Exposure in Healthy Individuals | p. 150 |
Clinical Improvement and Immunological Changes of Atopic Dermatitis in Patients Undergoing Subcutaneous Immunotherapy with Depigmented Polymerized House Dust Mite Allergens | p. 154 |
A Potent Adenosine A[subscript 2B] Receptor Antagonist Attenuates Methacholine-Induced Bronchial Hyperresponsiveness, Mucus Production, and IgE Levels in an Allergic Mouse Model | p. 156 |
Differential Regulation of Different TLR Responses by IL-10 Derived from Different Cell Types | p. 159 |
Pharmacodynamics of Latest Generation H[subscript 1]-Antihistamines; Relevance of Drug Concentrations at Receptor Sites and of Affinity Values for H[subscript 1] Receptors | p. 162 |
Conformational Change in the IgE-Fc[epsilon]RI Interaction as a Target for Inhibitor Design | p. 167 |
Protective Effects of CORM-3, a Water-Soluble Carbon-Monoxide Releasing Molecule, in a Model of Vascular Inflammation | p. 172 |
Insufficient T Regulatory Cell Expression and Function in Atopic Dermatitis Skin | p. 176 |
Hymenoptera Venom Allergy: A New Ultra-Rush Immunotherapy | p. 179 |
Anti-IgE Treatment Overcomes Intolerability of Honeybee-Venom Ultra-Rush Immunotherapy in Indolent Systemic Mastocytosis | p. 182 |
Immunomodulatory Effects of Viral Toll-Like Receptor Ligands: An Experimental Approach to the Hygiene Hypothesis | p. 184 |
Development of a Mucosal Polyvalent Allergy Vaccine for Primary Prevention of Multisensitization | p. 187 |
The Role of Advanced Glycation End Products in Asthma and Chronic Obstructive Pulmonary Disease | p. 191 |
Allergenicity and Immunogenicity of Commercially Available Allergoid Products for Birch Pollen Immunotherapy | p. 194 |
Human Antichimeric Antibodies to Infliximab and Infusion-Related Allergic Reactions in Patients with Rheumatoid Arthritis | p. 198 |
LAS 36674, A New Generation of H1 Antihistamines: From Bench to Bedside and Back | p. 201 |
Immune Effector Cells | |
[Beta]-Cell Development: From Bone Marrow to Peripheral Tissue in Allergy | p. 204 |
Parasites and Allergy: From Mice to Man | p. 208 |
C3a and C4a: Complement Split Products Identify Patients with Hyperacute Lyme Disease | p. 212 |
Plasma Cell Differentiation and Immunoglobulin Secretion Are Induced by Interleukin-4 and Anti-CD40 and Differ in Cord Blood and Adult Naive [Beta]-Cells | p. 216 |
Single Nucleotide Polymorphisms of CD14 Are Associated with the Development of Respiratory Syncytial Virus Bronchiolitis in Japanese Children | p. 220 |
CDS T-Cell - Dendritic Cell Cross-Talk | p. 223 |
Maternal Smoking in Pregnancy Suppresses Neonatal TLR-Mediated Microbial Responses, and This Effect Is Increased by Maternal Allergy | p. 227 |
The Molecular Basis of IgE-Mediated Autoreactivity | p. 237 |
The Stromal Microenvironment Is a Potent Regulator of Dendritic Cell Function | p. 239 |
Induction and Efficacy of Cytolytic Regulatory T-Cells in Experimental Asthma | p. 244 |
Antigen-Specific Expression of Lymphocyte Activation Markers CD69, CD25, and HLA-DR in Patients with Immediate Reactions to Amoxicillin | p. 247 |
Integration of Regulatory T-Cells into the Th1/Th2 Paradigm | p. 251 |
Association Between Epidermal Caspase- 3 Cleavage and Dermal Interferon-[gamma] Expressing Cells in Atopic Dermatitis | p. 256 |
Plasticity of Histamine H[subscript 1] Receptor Expression in Human Mononuclear Phagocytes | p. 259 |
The Role of NKT-Cells in the Development of Asthma | p. 263 |
Ten Years' Experience in Epidermal Dendritic Cell Phenotyping (EDCP) as a Diagnostic Tool | p. 267 |
Diseases of Impaired Barrier Function | |
Probability of Hospital Admission with Acute Asthma Exacerbation Increases with Increasing Specific IgE Antibody Levels | p. 270 |
IgE-Dependent Cytokine Release from Human Lung Tissue | p. 274 |
Detailed Sequence and Haplotype Analysis of the [beta]2 Adrenergic Receptor Gene in Caucasians and African Americans | p. 277 |
Atheroma - Another "Modern Disease" Explained by the Hygiene Hypothesis | p. 285 |
Systemic Corticosteroid Treatment Reduces Bronchial Mucosal Activation of Activator Protein-1 (AP-1) Components in Corticosteroid Sensitive, but Not Resistant Asthmatics | p. 288 |
Biphasic Itch Stimulus Model for Investigations Using Functional Magnetic Resonance Tomography | p. 293 |
Further Considerations on the Mechanisms of NSAID Hypersensitivity | p. 297 |
Mechanotransduction of uPA-uPAR in Airway Epithelial Cells | p. 301 |
Eosinophilic Esophagitis: Escalating Epidemiology? | p. 304 |
Interleukin-4 Regulates the Expression of Thymus- and Activation-Regulated Chemokine (TARC)/CCL17 by a Signal Transducer and Activator of Transcription 6 (STAT6)-Dependent Mechanism | p. 308 |
The Functional Role of Hepatocyte Growth factor in Allergic Inflammation | p. 312 |
Involvement of Periostin in Subepithelial Fibrosis of Bronchial Asthma Downstream of IL-4 and IL-13 Signals | p. 315 |
CD48 Is Critically Involved in Experimental Asthma | p. 318 |
Interaction of Allergic Rhinitis and Bacterial Sinusitis in a Mouse Model | p. 321 |
Retinol Concentrations After Birth Are Inversely Associated with Atopic Manifestations in Children and Young Adults | p. 324 |
Evaluation of Chronic Rhinosinusitis and the Role of Nitric Oxide Measurements | p. 327 |
Epigallocatechine-3-gallate Reduces Allergic Lung Inflammation in Guinea Pig Asthma-Like Reaction | p. 332 |
Epidemiology of the Allergic Respiratory Syndrome in Residents of Urban US Public Housing Communities | p. 336 |
Caspase Activation and Loss of Mitochondrial Membrane Potential Precedes Phosphatidylserine Exposure in CD45-Dependent Eosinophil Apoptosis | p. 339 |
Impact of IL-13 on Epidermal Inflammation in Atopic Dermatitis | p. 342 |
PPAR[gamma]- and Toll-Like Receptor-2 Agonists Might Have Therapeutical Value in Respiratory Syncytial Virus (RSV)-Induced Airway Disease: PPAR[gamma] Agonists May Act in a PPAR[gamma]-Independent Manner | p. 345 |
Author Index | |
Keyword Index | |
Table of Contents provided by Blackwell. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.